PT87701A - Process for preparing a device for the controlled delivery of a drug at a constant release rate - Google Patents

Process for preparing a device for the controlled delivery of a drug at a constant release rate

Info

Publication number
PT87701A
PT87701A PT87701A PT8770188A PT87701A PT 87701 A PT87701 A PT 87701A PT 87701 A PT87701 A PT 87701A PT 8770188 A PT8770188 A PT 8770188A PT 87701 A PT87701 A PT 87701A
Authority
PT
Portugal
Prior art keywords
drug
preparing
release rate
controlled delivery
constant release
Prior art date
Application number
PT87701A
Other languages
English (en)
Other versions
PT87701B (pt
Inventor
Gautam Ramchandra Ranade
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PT87701A publication Critical patent/PT87701A/pt
Publication of PT87701B publication Critical patent/PT87701B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0068—Rumen, e.g. rumen bolus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L9/00—Disinfection, sterilisation or deodorisation of air
    • A61L9/015—Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone
    • A61L9/04—Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone using substances evaporated in the air without heating
    • A61L9/05—Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone using substances evaporated in the air without heating specially adapted to be released by contact with a liquid, e.g. for toilets

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Extrusion Moulding Of Plastics Or The Like (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • External Artificial Organs (AREA)
  • Communication Control (AREA)
  • Saccharide Compounds (AREA)
  • Paper (AREA)
  • Cephalosporin Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PT87701A 1987-06-11 1988-06-09 Processo para a preparacao de um dispositivo para a administracao controlada dum medicamento segundo uma taxa de libertacao constante PT87701B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/061,925 US4792448A (en) 1987-06-11 1987-06-11 Generic zero order controlled drug delivery system

Publications (2)

Publication Number Publication Date
PT87701A true PT87701A (pt) 1988-07-01
PT87701B PT87701B (pt) 1992-09-30

Family

ID=22039041

Family Applications (1)

Application Number Title Priority Date Filing Date
PT87701A PT87701B (pt) 1987-06-11 1988-06-09 Processo para a preparacao de um dispositivo para a administracao controlada dum medicamento segundo uma taxa de libertacao constante

Country Status (26)

Country Link
US (1) US4792448A (pt)
EP (1) EP0294993B1 (pt)
JP (1) JPH0688900B2 (pt)
KR (1) KR900004092B1 (pt)
CN (1) CN1018151B (pt)
AT (1) ATE64850T1 (pt)
AU (1) AU598938B2 (pt)
CA (1) CA1326821C (pt)
CS (1) CS274431B2 (pt)
DD (1) DD284599A5 (pt)
DE (1) DE3863493D1 (pt)
DK (1) DK175285B1 (pt)
EG (1) EG18919A (pt)
ES (1) ES2022988B3 (pt)
FI (1) FI94025C (pt)
GR (1) GR3002260T3 (pt)
IE (1) IE61123B1 (pt)
IL (1) IL86631A (pt)
MY (1) MY101285A (pt)
NO (1) NO176162C (pt)
NZ (1) NZ224981A (pt)
PH (1) PH25174A (pt)
PT (1) PT87701B (pt)
RU (1) RU2072835C1 (pt)
YU (1) YU46569B (pt)
ZA (1) ZA884163B (pt)

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8815968D0 (en) * 1988-07-05 1988-08-10 Pfizer Ltd Veterinary devices
GB8820353D0 (en) * 1988-08-26 1988-09-28 Staniforth J N Controlled release tablet
US4981870A (en) * 1989-03-07 1991-01-01 Pfizer Inc. Use of 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives in the treatment of psychosis, inflammation and as immunosuppressants
US5591454A (en) * 1989-09-05 1997-01-07 Alza Corporation Method for lowering blood glucose
US6361795B1 (en) * 1989-09-05 2002-03-26 Alza Corporation Method for lowering blood glucose
US5629008A (en) * 1992-06-02 1997-05-13 C.R. Bard, Inc. Method and device for long-term delivery of drugs
US5256440A (en) * 1992-06-22 1993-10-26 Merck & Co., Inc. Process for producing a tablet core aperture
US5343550A (en) * 1993-02-25 1994-08-30 The United States Of America As Represented By The United States National Aeronautics And Space Administration Transversely polarized source cladding for an optical fiber
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5773025A (en) 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US6726930B1 (en) 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
EP0758244B2 (en) 1994-05-06 2008-02-13 Pfizer Inc. Controlled-release dosage forms of azithromycin
US5534263A (en) 1995-02-24 1996-07-09 Alza Corporation Active agent dosage form comprising a matrix and at least two insoluble bands
EP0811374A1 (en) 1996-05-29 1997-12-10 Pfizer Inc. Combination dosage form comprising cetirizine and pseudoephedrine
EP0910345B1 (en) 1996-06-17 2002-02-13 Janssen Pharmaceutica N.V. Biconvex rapidly disintegrating dosage forms
EP0859603B1 (en) 1996-07-08 2008-12-17 Penwest Pharmaceuticals Co. Sustained release matrix for high-dose insoluble drugs
US5968895A (en) * 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US5837379A (en) * 1997-01-31 1998-11-17 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
US5922352A (en) * 1997-01-31 1999-07-13 Andrx Pharmaceuticals, Inc. Once daily calcium channel blocker tablet having a delayed release core
US20030133974A1 (en) * 1997-07-01 2003-07-17 Curatolo William John Encapsulated solution dosage forms of sertraline
HUP0002296A3 (en) 1997-07-01 2001-11-28 Pfizer Sertraline salts and sustained-release dosage forms of sertraline
US20040208926A1 (en) * 1997-07-01 2004-10-21 Pfizer Inc Solubilized sertraline compositions
PT1003476E (pt) * 1997-08-11 2005-05-31 Alza Corp Forma de dosagem de agente activo de libertacao prolongada adaptada para retencao gastrica
US6056977A (en) 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US6485748B1 (en) 1997-12-12 2002-11-26 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
DE19814256A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
US6365183B1 (en) * 1998-05-07 2002-04-02 Alza Corporation Method of fabricating a banded prolonged release active agent dosage form
KR100463496B1 (ko) * 1999-09-30 2005-01-06 펜웨스트 파머슈티칼즈 컴파니 고가용성 약물용 서방성 메트리스 시스템
RU2200002C1 (ru) * 2001-07-30 2003-03-10 Акционерное Курганское общество медицинских препаратов и изделий "Синтез" Твердая фармацевтическая композиция и способ ее получения
RU2190392C1 (ru) * 2001-09-14 2002-10-10 Нестерук Владимир Викторович Фармацевтическая композиция на основе доксазозина
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
US7323192B2 (en) 2001-09-28 2008-01-29 Mcneil-Ppc, Inc. Immediate release tablet
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
CA2447984A1 (en) 2001-09-28 2003-04-03 Mcneil-Ppc, Inc. Dosage forms having an inner core and outer shell with different shapes
US6982094B2 (en) 2001-09-28 2006-01-03 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US7217381B2 (en) 2001-09-28 2007-05-15 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US6837696B2 (en) 2001-09-28 2005-01-04 Mcneil-Ppc, Inc. Apparatus for manufacturing dosage forms
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
US6602911B2 (en) 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
RU2191573C1 (ru) * 2001-11-14 2002-10-27 Нестерук Владимир Викторович Способ получения антибактериального средства на основе доксициклина
ITMI20020515A1 (it) * 2002-03-12 2003-09-12 Jagotec Ag Sistema per il rilasco controllato di uno o piu' principi attivi
CA2481025A1 (en) 2002-04-04 2003-10-16 Tanya Havlir Palatable chewable tablet
CN100435880C (zh) * 2003-02-28 2008-11-26 微创医疗器械(上海)有限公司 一种药物洗脱介入医疗器械及其制备方法
US7807197B2 (en) 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
US20040131672A1 (en) * 2003-01-07 2004-07-08 Nilobon Podhipleux Direct compression pharmaceutical composition containing a pharmaceutically active ingredient with poor flowing properties
JP3811127B2 (ja) * 2003-01-30 2006-08-16 株式会社東芝 情報記録装置及び情報記録方法
US20050169994A1 (en) * 2003-11-25 2005-08-04 Burke Matthew D. Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
WO2005051322A2 (en) * 2003-11-25 2005-06-09 Sb Pharmco Puerto Rico Inc. Controlled release pharmaceutical formulations comprising carvedilol, free based and its salts
US9492541B2 (en) * 2004-09-14 2016-11-15 Sovereign Pharmaceuticals, Llc Phenylepherine containing dosage form
WO2005060946A1 (en) * 2003-12-17 2005-07-07 Pfizer Products Inc. Continuous combination therapy with selective prostaglandin ep4, receptor agonists and an estrogen for the treatment of conditions that present with low bone mass
EP2594259A1 (en) 2004-08-04 2013-05-22 Brookwood Pharmaceuticals, Inc. Methods for manufacturing delivery devices and devices thereof
WO2006084083A2 (en) * 2005-02-03 2006-08-10 Duramed Pharmaceuticals, Inc. Devices for delivering agents to a vaginal tract
AU2006226742A1 (en) * 2005-03-24 2006-09-28 E. I. Du Pont De Nemours & Company Transponder overmolded with ethylene copolymers
US7544373B2 (en) * 2007-04-02 2009-06-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US8722650B1 (en) 2005-06-24 2014-05-13 Medicis Pharmaceutical Corporation Extended-release minocycline dosage forms
US20080241235A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7919483B2 (en) * 2005-06-24 2011-04-05 Medicis Pharmaceutical Corporation Method for the treatment of acne
US8252776B2 (en) 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7541347B2 (en) * 2007-04-02 2009-06-02 Medicis Pharmaceutical Coropration Minocycline oral dosage forms for the treatment of acne
US20080242642A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US9192615B2 (en) 2008-08-06 2015-11-24 Medicis Pharmaceutical Corporation Method for the treatment of acne and certain dosage forms thereof
US7994220B2 (en) 2005-09-28 2011-08-09 Cypress Bioscience, Inc. Milnacipran for the long-term treatment of fibromyalgia syndrome
EP1859788A1 (en) * 2006-05-24 2007-11-28 Abbott GmbH & Co. KG Production of enveloped pharmaceutical dosage forms
WO2008093578A1 (ja) * 2007-01-30 2008-08-07 Olympus Medical Systems Corp. 管腔通過確認装置、その溶解方法および製造方法
US20080241197A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline dosage forms for the treatment of acne
CA2775079A1 (en) * 2009-09-22 2011-03-31 Evonik Degussa Corporation Implant devices for modulating bioactive agent release profiles
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline
JP5879979B2 (ja) 2011-11-30 2016-03-08 ブラザー工業株式会社 分離片ユニットおよびシート搬送装置
GB2498999A (en) 2012-02-02 2013-08-07 Siemens Plc Mechanical superconducting switch
CN104490838B (zh) * 2014-11-20 2017-03-01 河北医科大学 一种骨架型缓控释片剂及其制备方法和应用
USD765828S1 (en) 2015-02-19 2016-09-06 Crossford International, Llc Chemical tablet
USD789514S1 (en) * 2016-06-01 2017-06-13 David Hill Injectable tablet
US10583089B2 (en) 2016-07-19 2020-03-10 Johnson & Johnson Consumer Inc. Tablets having discontinuous coated regions
CA3242369A1 (en) * 2016-07-19 2018-01-25 Johnson & Johnson Consumer Inc. (A Delaware Corporation) Tablets having discontinuous coated regions
AU2019275406B2 (en) 2018-05-24 2024-11-14 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound
WO2019226519A1 (en) 2018-05-24 2019-11-28 Celanese EVA Performance Polymers Corporation Implantable device for sustained release of a macromolecular drug compound
WO2019222856A1 (en) 2018-05-24 2019-11-28 Nureva Inc. Method, apparatus and computer-readable media to manage semi-constant (persistent) sound sources in microphone pickup/focus zones
US12163326B1 (en) * 2019-10-01 2024-12-10 NeverClog, LLC System for capturing and destroying hair or waste within a commercial shower drain
JP7703137B2 (ja) 2020-02-03 2025-07-07 ケンビュー・ブランズ・エルエルシー セチリジンを含む単層チュアブル錠剤
PT4037666T (pt) 2020-12-08 2024-06-25 Ruminant Biotech Corp Ltd Aperfeiçoamentos de dispositivos e métodos para administração de substâncias a animais
WO2022231930A1 (en) 2021-04-26 2022-11-03 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound
USD979043S1 (en) * 2021-04-29 2023-02-21 Kurt A. Van Tine Tablet

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2539036A (en) * 1946-04-25 1951-01-23 Schwab Fritz Arrangement for applying chemicals and minerals for therapeutical purposes
US3113076A (en) * 1956-07-03 1963-12-03 Henry R Jacobs Medicinal tablets
GB972128A (en) * 1960-01-21 1964-10-07 Wellcome Found Pellets for supplying biologically active substances to ruminants and the manufacture of such pellets
NL175029C (nl) * 1970-12-23 1984-09-17 Boehringer Sohn Ingelheim Depotdragee, die bekleed is met een onoplosbare en onverteerbare schaal, die op een of meer plaatsen een uitsparing vertoont.
AT341100B (de) * 1972-12-27 1978-01-25 Alza Corp Verfahren zur herstellung eines korpers bzw. einer vorrichtung zur abgabe mit gesteuerter geschwindigkeit eines aktiven mittels
US3851648A (en) * 1973-10-11 1974-12-03 Mead Johnson & Co Zero-order release device
CH646330A5 (en) * 1980-05-21 1984-11-30 Ciba Geigy Ag Divisible slow-release pharmaceutical tablets
AU8363582A (en) * 1981-06-15 1982-12-23 Bally Manufacturing Corp. Surface projectile game
GB2110524B (en) * 1981-12-05 1985-06-12 Ronald Poppleton Hill Apparatus for dispensing a volatile material
US4690824A (en) * 1983-07-07 1987-09-01 Redi-Rowell, Inc. Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion: expanded range
AU591171B2 (en) * 1983-11-02 1989-11-30 Alza Corporation Dispenser for delivering thermo-responsive composition
IN162525B (pt) * 1984-02-08 1988-06-04 Pfizer
US4609374A (en) * 1985-04-22 1986-09-02 Alza Corporation Osmotic device comprising means for governing initial time of agent release therefrom
US4673565A (en) * 1985-05-03 1987-06-16 E. I. Du Pont De Nemours And Company Pharmaceutical compositions containing hollow fine tubular drug delivery systems
GB8514666D0 (en) * 1985-06-11 1985-07-10 Coopers Animal Health Agent delivery systems
US4663147A (en) * 1985-09-03 1987-05-05 International Minerals & Chemical Corp. Disc-like sustained release formulation

Also Published As

Publication number Publication date
KR890000081A (ko) 1989-03-11
EG18919A (en) 1994-06-30
FI94025B (fi) 1995-03-31
ATE64850T1 (de) 1991-07-15
FI94025C (fi) 1995-07-10
YU46569B (sh) 1993-11-16
EP0294993A1 (en) 1988-12-14
NO176162B (no) 1994-11-07
CS401188A2 (en) 1990-08-14
RU2072835C1 (ru) 1997-02-10
ZA884163B (en) 1990-02-28
DD284599A5 (de) 1990-11-21
CA1326821C (en) 1994-02-08
FI882780A0 (fi) 1988-06-10
MY101285A (en) 1991-08-17
IE61123B1 (en) 1994-10-05
GR3002260T3 (en) 1992-12-30
NO882565D0 (no) 1988-06-10
IL86631A (en) 1991-09-16
ES2022988B3 (es) 1991-12-16
IE881763L (en) 1988-12-11
DK318788D0 (da) 1988-06-10
PT87701B (pt) 1992-09-30
PH25174A (en) 1991-03-27
US4792448A (en) 1988-12-20
NZ224981A (en) 1991-07-26
CN1018151B (zh) 1992-09-09
YU112688A (en) 1990-04-30
JPH0688900B2 (ja) 1994-11-09
JPS649930A (en) 1989-01-13
EP0294993B1 (en) 1991-07-03
FI882780L (fi) 1988-12-12
NO176162C (no) 1995-02-15
DE3863493D1 (de) 1991-08-08
IL86631A0 (en) 1988-11-30
KR900004092B1 (ko) 1990-06-15
DK175285B1 (da) 2004-08-09
AU598938B2 (en) 1990-07-05
AU1761488A (en) 1988-12-15
CN1030358A (zh) 1989-01-18
CS274431B2 (en) 1991-04-11
NO882565L (no) 1988-12-12
DK318788A (da) 1989-02-06

Similar Documents

Publication Publication Date Title
NO176162C (no) Fremgangsmåte for fremstilling av en anordning for kontrollert medikamentavgivelse
FI873822A0 (fi) Väline vaikuttavan aineen vapauttamiseksi kontrolloidusti ja menetelmä sen valmistamiseksi
PT88854A (pt) Sistema para a libertacao controlada dum medicamento benefico
ATE63059T1 (de) Vorrichtung mit zwei schichten zur freisetzung von arzneimitteln.
DK287982A (da) Fremgangsmaade til tidsstyring af frigoerelsen af aktive stoffer fra midler med indhold deraf navnlig fra farmaceutiske praeparater
IT8720708A0 (it) Sistema terapeutico per la cessione controllata di farmaci.

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19920313

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20060913